David Andrews, Senior Director, Oncology Chemistry, Oncology R&D at AstraZeneca shared a post on LinkedIn:
“Biggest (and most recurring) learning since 1977 ?
BELIEVE IN YOURSELF: ‘He comes out with the occasional flash of inspiration which suggests that, if he knew the work, progress would be rapid.’
Last day today as an employee after 36 years in medicines R/D – retirement, here I come! Thank you to everyone at Glaxo, GSK and especially AstraZeneca-particularly the Oncology Chemistry community-for the friendship and support down the years.
I’ll be a bit quiet for a few weeks: late May/early June I’m cycling Land’s End to John O’Groats. With a heart that prefers syncopation and a riding partner who’s already donated a kidney to his son, we’ve decided to take our remaining organs on a celebratory tour of Britain. (Translation: contact may resume mid June.)
Trip updates on Instagram and Strava. Stay curious, and stay in touch.”
Other articles on OncoDaily.